These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 25834613)
1. Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma. Jung NY; Kim SH; Kim SH; Seo YY; Oh JK; Choi HS; You WJ J Breast Cancer; 2015 Mar; 18(1):63-72. PubMed ID: 25834613 [TBL] [Abstract][Full Text] [Related]
2. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma. Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295 [TBL] [Abstract][Full Text] [Related]
3. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers. Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766 [TBL] [Abstract][Full Text] [Related]
5. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma. Jung NY; Kim SH; Choi BB; Kim SH; Sung MS World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560 [TBL] [Abstract][Full Text] [Related]
6. [Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma]. Diekmann F; Diekmann S; Beljavskaja M; Bick U; Taupitz M; Blohmer JU; Winzer KJ; Hamm B Rofo; 2004 Apr; 176(4):544-9. PubMed ID: 15088179 [TBL] [Abstract][Full Text] [Related]
7. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796 [TBL] [Abstract][Full Text] [Related]
8. Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI. Park HL; Yoo IR; O JH; Kim H; Kim SH; Kang BJ Nucl Med Commun; 2018 Jan; 39(1):35-43. PubMed ID: 28984814 [TBL] [Abstract][Full Text] [Related]
9. Prospective Pilot Study of Covington MF; Hoffman JM; Morton KA; Buckway B; Boucher KM; Rosenthal RE; Porretta JM; Brownson KE; Matsen CB; Vaklavas C; Ward JH; Wei M; Buys SS; Chittoria N; Yakish ED; Archibald ZG; Burrell LD; Butterfield RI; Yap JT AJR Am J Roentgenol; 2023 Aug; 221(2):228-239. PubMed ID: 36919879 [No Abstract] [Full Text] [Related]
12. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype. Dashevsky BZ; Goldman DA; Parsons M; Gönen M; Corben AD; Jochelson MS; Hudis CA; Morrow M; Ulaner GA Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1666-1673. PubMed ID: 25971426 [TBL] [Abstract][Full Text] [Related]
13. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Kim HJ; Cho A; Yun M; Kim YT; Kang WJ Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334 [TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
15. Axillary Lymph Node-to-Primary Tumor Standard Uptake Value Ratio on Preoperative (18)F-FDG PET/CT: A Prognostic Factor for Invasive Ductal Breast Cancer. Kim YH; Yoon HJ; Kim Y; Kim BS J Breast Cancer; 2015 Jun; 18(2):173-80. PubMed ID: 26155294 [TBL] [Abstract][Full Text] [Related]
16. Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma. Mushtaq A; Lawal IO; Muzahir S; Friend SC; Bhave M; Meisel JL; Torres MA; Styblo TM; Graham CL; Kalinsky K; Switchenko J; Ulaner GA; Schuster DM Eur J Nucl Med Mol Imaging; 2024 Nov; 51(13):4073-4082. PubMed ID: 38976035 [TBL] [Abstract][Full Text] [Related]
17. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma. Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703 [TBL] [Abstract][Full Text] [Related]
18. Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS? Sarikaya I; Sarikaya A; Albatineh AN; Tastekin E; Sezer YA Asia Ocean J Nucl Med Biol; 2020; 8(1):27-35. PubMed ID: 32064280 [TBL] [Abstract][Full Text] [Related]
19. A review on the added value of whole-body MRI in metastatic lobular breast cancer. Bhaludin BN; Tunariu N; Koh DM; Messiou C; Okines AF; McGrath SE; Ring AE; Parton MM; Sharma B; Gagliardi T; Allen SD; Pope R; Johnston SRD; Downey K Eur Radiol; 2022 Sep; 32(9):6514-6525. PubMed ID: 35384456 [TBL] [Abstract][Full Text] [Related]
20. Population-based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node-positive invasive lobular carcinoma of the breast. Morrow E; Lannigan A; Doughty J; Litherland J; Mansell J; Stallard S; Mallon E; Romics L Br J Surg; 2018 Jul; 105(8):987-995. PubMed ID: 29623677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]